INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 19 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $490,000 | -50.6% | 80,392 | -23.1% | 0.00% | 0.0% |
| Q3 2016 | $991,000 | +26.9% | 104,508 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $781,000 | +153.6% | 104,939 | +151.9% | 0.00% | – |
| Q1 2016 | $308,000 | -24.5% | 41,652 | +15.5% | 0.00% | -100.0% |
| Q4 2015 | $408,000 | +20.7% | 36,052 | +0.3% | 0.00% | – |
| Q3 2015 | $338,000 | +8350.0% | 35,955 | +4694.0% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 750 | -33.8% | 0.00% | – |
| Q1 2015 | $6,000 | – | 1,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $30,491,000 | 15.27% |
| RHO CAPITAL PARTNERS INC | 2,870,584 | $26,983,000 | 8.96% |
| Private Capital Advisors, Inc. | 293,000 | $2,754,000 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 295,000 | $2,773,000 | 0.35% |
| Meditor Group Ltd | 51,111 | $480,000 | 0.25% |
| EverPoint Asset Management, LLC | 825,000 | $7,755,000 | 0.20% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,392,000 | 0.16% |
| EAM Investors, LLC | 99,428 | $935,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 26,800 | $252,000 | 0.14% |
| Tekla Capital Management LLC | 425,000 | $3,995,000 | 0.14% |